NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation i...

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split...

NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growt...

NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32,...

NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discover...

PMGC Holdings Inc. Announces the Acquisition of SVM Machining, Inc....

PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026...

PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nucl...

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split...